Published date: 3 May 2017
This notice was replaced on 18 May 2018
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 18 May 2018, last edited 4 January 2021)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Vaccines - 33651600
Location of contract
Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands
Value of contract
£0
Procurement reference
CM_PHV_12_5392
Published date
3 May 2017
Closing date
5 June 2017
Contract start date
1 April 2018
Contract end date
31 March 2020
Contract type
Supply contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The provision of a vaccine to protect against tuberculosis, to be used in the national immunisation programme.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
More information
Attachments
-
- OJEU_ITO Docs_BCG vaccine.zip
- Contract notice
- OJEU_ITO Docs_BCG vaccine
Additional text
-
This publication is to notify the market of a current opportunity that exists to supply BCG vaccine. Attachments include a copy of the published OJEU notice along with the ITO documents that have been published via the Bravo e-tendering portal.
About the buyer
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
All content is available under the
